{
    "nctId": "NCT01279018",
    "briefTitle": "Persistent Pain After Breast Cancer Treatment With Docetaxel",
    "officialTitle": "Persistent Pain After Breast Cancer Treatment With Docetaxel",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Pain, Postoperative, Neuralgia, Lymphedema",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 2490,
    "primaryOutcomeMeasure": "Docetaxel as a risk factor for development of persistent pain",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Treated for primary breast cancer in Denmark 2007-2008\n* Age between 18-80 years\n* No recurrent cancer\n* Female\n\nExclusion Criteria:\n\n* Previous breast surgery same side (including plastic and reconstructive surgery)\n* Bilateral breast surgery\n* Recurrent cancer or metastatic cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}